Gemcitabine base
CAS: 95058-81-4
Rif. 3D-ND04237
10g | 349,00 € | ||
25g | 652,00 € | ||
50g | 993,00 € | ||
100g | 1.496,00 € | ||
250g | 2.804,00 € |
Informazioni sul prodotto
- 2-Deoxy-2',2'-difluorocytidine4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one2'-Deoxy-2',2'-difluor o-D-cytidine2',2'-Difluoro-2'-deoxycytidine
- Gemcitabine
- Cytidine, 2′-deoxy-2′,2′-difluoro-
- LY 188011
- DDFC
- 2′-Deoxy-2′,2′-difluorocytidine
Gemcitabine is a prodrug that is converted to 5-fluorouracil (5FU) in the body. It has been shown to inhibit the growth of bladder and pancreatic cancer cells by interfering with the synthesis of DNA. Gemcitabine inhibits DNA replication by binding to the epidermal growth factor receptor, which leads to cell death. Gemcitabine also acts as a competitive inhibitor of deoxycytidine kinase, which prevents the formation of deoxycytidine monophosphate from deoxyuridine monophosphate, preventing DNA replication. In addition, gemcitabine can activate apoptosis in some tumor cells by increasing levels of intracellular free calcium, which leads to activation of enzymes such as phospholipases and proteases that degrade proteins, lipids, and nucleic acids.
Proprietà chimiche
Richiesta tecnica su: 3D-ND04237 Gemcitabine base
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.